Design, synthesis, antifungal activity, and ADME prediction of functional analogues of terbinafine

被引:39
作者
Kharkar, Prashant S. [2 ]
Deodhar, Meenakshi N. [1 ]
Kulkarni, Vithal M. [1 ]
机构
[1] Bharati Vidyapeeth Univ, Dept Pharmaceut Chem, Poona Coll Pharm, Pune 411038, Maharashtra, India
[2] Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48202 USA
关键词
Terbinafine; Quinoline derivatives; LeapFrog; Antifungal activity; ADME prediction; Toxicity evaluation; ALLYLAMINE ANTIMYCOTIC TERBINAFINE; FUNGAL SQUALENE EPOXIDASE; INFECTIONS; AGENT; BIOSYNTHESIS; EPIDEMIOLOGY; FLUCONAZOLE; DERIVATIVES; ERGOSTEROL; THERAPY;
D O I
10.1007/s00044-008-9138-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
From the earlier quantitative structure-activity relationship (QSAR) and molecular modeling studies, a series of quinoline derivatives 5a-h mimicking terbinafine and containing different bulky aromatic rings in the side chain were designed using LeapFrog, a de novo drug design program. The designed compounds were synthesized and screened for antifungal activity in vitro against C. albicans. Of the ten compounds designed and synthesized, compounds 5c, d, f, h, and i exhibited minimum inhibitory concentration (MIC) in the range 4-25 mu g/ml and were further evaluated for oral toxicity in animal model. The pharmacokinetic properties for these compounds were estimated in silico and compared with terbinafine. Compound 5h, N-methyl-N-[(2-naphthyl)methyl]-8-quinolinemethanamine, was found to be least toxic, possessing pharmacokinetic parameters close to those of terbinafine.
引用
收藏
页码:421 / 432
页数:12
相关论文
共 26 条
[1]   EMERGENCE OF CANDIDA-KRUSEI INFECTIONS AFTER THERAPY OF OROPHARYNGEAL CANDIDIASIS WITH FLUCONAZOLE [J].
AKOVA, M ;
AKALIN, HE ;
UZUN, O ;
GUR, D .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (07) :598-599
[2]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[3]   In silico prediction of ADME and pharmacokinetics - Report of an expert meeting organised by COST B15 [J].
Boobis, A ;
Gundert-Remy, U ;
Kremers, P ;
Macheras, P ;
Pelkonen, O .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 17 (4-5) :183-193
[4]   Computational methods for the prediction of 'drug-likeness' [J].
Clark, DE ;
Pickett, SD .
DRUG DISCOVERY TODAY, 2000, 5 (02) :49-58
[5]   VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD [J].
CLARK, M ;
CRAMER, RD ;
VANOPDENBOSCH, N .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) :982-1012
[6]  
DENNING DW, 1991, J ANTIMICROB CHEMOTH, V28, P1, DOI 10.1093/jac/28.suppl_B.1
[7]  
DIAMOND RD, 1991, REV INFECT DIS, V13, P480
[8]   Comparative molecular field analysis of fungal squalene epoxidase inhibitors [J].
Gokhale, VM ;
Kulkarni, VM .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (26) :5348-5358
[9]  
Hawkey P.M., 1994, Medical Bacterology: A. Practical Approach, P181, DOI DOI 10.4236/FNS.2017.81008